EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort

Katia F Ávila-Fernández, Héctor Martínez-Said, Ivan R González-Espinoza, Rodrigo R Flores-Mariñelarena, Gabriela Juárez-Salazar, Mariana Chiquillo-Dominguéz, Abraham Castro-Ponce, Julio C Garibay-Díaz, Jerónimo R Rodríguez-Cid

Cancer Treatment and Research Communications · 2025

DOI: 10.1016/j.ctarc.2025.100973 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Katia F Ávila-Fernández und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, South Medica Hospital, Puente de Piedra 150 14050, Mexico City, Mexico. Electronic address: katia.avilafdez@icloud.com. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Melanoma is currently the most aggressive skin cancer. It is currently categorized based on mutations that have been studied for their prognostic relevance. OBJECTIVE: Define the epidemiology of mutations in patients with melanoma in Mexico using the Next-Generation Sequencing technology and explore its prognosis utility in terms of prognosis. METHODS: A descriptive, multicentric, analytical, and retrospective study was conducted on sixteen patients with melanoma and NGS. RESULTS: Sixteen patients with nodular, lentiginous acral melanoma, and superficial extension were included. We found sixteen different mutations in the melanoma samples. The most frequent mutation in our population was the BRAF mutation (56.3 %); the CCND1 and NRAS mutations were found in 18.8 %. There was a statistically significant association between NRAS and mortality. Median progression-free survival was 27 months (95 % CI = 6.5-47.42 months) and median overall survival was 40.18 months (95 % CI = 19.03 - 61.3 months). The frequency of the mutations we found is similar to the ones reported in the literature, except for CD274, ROS1, and CDKN2A/B, which are more common in our population. We only found a prognostic value with NRAS, even though there is some evidence of mortality associated with other mutations. CONCLUSION: NGS is a useful tool that can detect multiple mutations in the same patient. Detecting profiles with prognostic values and mutations for targeted therapy is an option for these patients, however, the usefulness of these results must be further studied in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansMaleFemaleRetrospective StudiesMexicoMiddle AgedPrognosisAgedMutationAdultHigh-Throughput Nucleotide SequencingGTP PhosphohydrolasesBiomarkers, TumorMembrane ProteinsAged, 80 and overProto-Oncogene Proteins B-raf

Stichwörter der Autor:innen

IncidenceMelanomaMutationsNext-generation, sequencingPrognostic

Substanzen

NRAS protein, humanGTP PhosphohydrolasesBiomarkers, TumorMembrane ProteinsBRAF protein, humanProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Internal Medicine Department, South Medica Hospital, Puente de Piedra 150 14050, Mexico City, Mexico. Electronic address: katia.avilafdez@icloud.com.
  • Melanoma Clinic, National Cancer Institute, Av. San Fernando 22 14080, Mexico City, Mexico. Electronic address: mtzsaid@hotmail.com.
  • Hospital Angeles Puebla, Av. Kepler 2143 72190, Puebla, Mexico. Electronic address: vanvanmed@hotmail.com.
  • Internal Medicine Department, South Medica Hospital, Puente de Piedra 150 14050, Mexico City, Mexico. Electronic address: fm.rodrigorafael@gmail.com.
  • Hospital Angeles Puebla, Av. Kepler 2143 72190, Puebla, Mexico. Electronic address: juarez22gaby.sal@hotmail.com.
  • Hospital Angeles Puebla, Av. Kepler 2143 72190, Puebla, Mexico. Electronic address: mariana.chiqui.d@googlemail.com.

Zitieren

APA

Ávila-Fernández, K. F., Martínez-Said, H., González-Espinoza, I. R., Flores-Mariñelarena, R. R., Juárez-Salazar, G., Chiquillo-Dominguéz, M., Castro-Ponce, A., Garibay-Díaz, J. C., & Rodríguez-Cid, J. R. (2025). Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100973

Vancouver

Ávila-Fernández KF, Martínez-Said H, González-Espinoza IR, Flores-Mariñelarena RR, Juárez-Salazar G, Chiquillo-Dominguéz M, et al. Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.100973

BibTeX
@article{vilaFernndez2025,
  author = {Ávila-Fernández, Katia F and Martínez-Said, Héctor and González-Espinoza, Ivan R and Flores-Mariñelarena, Rodrigo R and Juárez-Salazar, Gabriela and Chiquillo-Dominguéz, Mariana and Castro-Ponce, Abraham and Garibay-Díaz, Julio C and Rodríguez-Cid, Jerónimo R},
  title = {Epidemiological description of genetic alterations and prognosis in Mexican patients with melanoma: a retrospective cohort},
  journal = {Cancer Treatment and Research Communications},
  year = {2025},
  doi = {10.1016/j.ctarc.2025.100973}
}
Kostenlos starten →